Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research[1].
[1]. Bilge DebeleÇ-BÜtÜner, et al. Cycloartane-type sapogenol derivatives inhibit NF-κB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids. 2018 Jul;135:9-20.
















